Pseudohyperaldosteronism Due to Licorice: A Practice-Based Learning from a Case Series.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
07 Jul 2024
Historique:
received: 31 05 2024
revised: 28 06 2024
accepted: 04 07 2024
medline: 13 7 2024
pubmed: 13 7 2024
entrez: 13 7 2024
Statut: epublish

Résumé

Pseudohyperaldosteronism (PHA) is characterized by hypertension, hypokalemia, and a decrease in plasma renin and aldosterone levels. It can be caused by several causes, but the most frequent is due to excess intake of licorice. The effect is mediated by the active metabolite of licorice, glycyrrhetinic acid (GA), which acts by blocking the 11-hydroxysteroid dehydrogenase type 2 and binding to the mineralocorticoid receptor (MR) as an agonist. The management of licorice-induced PHA depends on several individual factors, such as age, gender, comorbidities, duration and amount of licorice intake, and metabolism. The clinical picture usually reverts upon licorice withdrawal, but sometimes mineralocorticoid-like effects can be critical and persist for several weeks, requiring treatment with MR blockers and potassium supplements. Through this case series of licorice-induced PHA, we aim to increase awareness about exogenous PHA, and the possible risk associated with excess intake of licorice. An accurate history is mandatory in patients with hypertension and hypokalemia to avoid unnecessary testing. GA is a component of several products, such as candies, breath fresheners, beverages, tobacco, cosmetics, and laxatives. In recent years, the mechanisms of action of licorice and its active compounds have been better elucidated, suggesting its benefits in several clinical settings. Nevertheless, licorice should still be consumed with caution, considering that licorice-induced PHA is still an underestimated condition, and its intake should be avoided in patients with increased risk of licorice toxicity due to concomitant comorbidities or interfering drugs.

Identifiants

pubmed: 39000561
pii: ijms25137454
doi: 10.3390/ijms25137454
pii:
doi:

Substances chimiques

Glycyrrhetinic Acid P540XA09DR
11-beta-Hydroxysteroid Dehydrogenase Type 2 EC 1.1.1.146
Aldosterone 4964P6T9RB
Renin EC 3.4.23.15

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Auteurs

Chiara Sabbadin (C)

Unit of Endocrinology, University Hospital of Padua, 35128 Padua, Italy.
Department of Medicine (DIMED), University of Padua, 35128 Padua, Italy.

Andrea Graziani (A)

Unit of Endocrinology, University Hospital of Padua, 35128 Padua, Italy.
Department of Medicine (DIMED), University of Padua, 35128 Padua, Italy.

Alessandro Bavaresco (A)

Unit of Endocrinology, University Hospital of Padua, 35128 Padua, Italy.
Department of Medicine (DIMED), University of Padua, 35128 Padua, Italy.

Pierluigi Mazzeo (P)

Unit of Endocrinology, University Hospital of Padua, 35128 Padua, Italy.
Department of Medicine (DIMED), University of Padua, 35128 Padua, Italy.

Irene Tizianel (I)

Unit of Endocrinology, University Hospital of Padua, 35128 Padua, Italy.
Department of Medicine (DIMED), University of Padua, 35128 Padua, Italy.

Filippo Ceccato (F)

Unit of Endocrinology, University Hospital of Padua, 35128 Padua, Italy.
Department of Medicine (DIMED), University of Padua, 35128 Padua, Italy.

Decio Armanini (D)

Department of Medicine (DIMED), University of Padua, 35128 Padua, Italy.

Mattia Barbot (M)

Unit of Endocrinology, University Hospital of Padua, 35128 Padua, Italy.
Department of Medicine (DIMED), University of Padua, 35128 Padua, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH